About EMN
EMN is a company based in Toronto (Canada) founded in 2016 by Timothy Ormond and Eric J Zimmerman.. EMN has raised $6.2 million across 3 funding rounds from investors including Ajinomoto, dsm-firmenich and PeakBridge VC. EMN offers products and services including ENROUTE and ISOLUTION. EMN operates in a competitive market with competitors including MEND, Lanhao Biotech, Synofit, Collagen Msm Plus and Interpath Global, among others.
- Headquarter Toronto, Canada
- Founders Timothy Ormond, Eric J Zimmerman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enhanced Medical Nutrition Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.2 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series A
Jan 14, 2025
-
Investors
Ajinomoto
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EMN
EMN offers a comprehensive portfolio of products and services, including ENROUTE and ISOLUTION. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A program designed to accelerate patient recovery after surgery.
A supplement to support high protein needs in critical illness.
Unlock access to complete
Unlock access to complete
Funding Insights of EMN
EMN has successfully raised a total of $6.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $5.0M
-
First Round
First Round
(19 Feb 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series A - EMN | Valuation | dsm firmenich | |
| Oct, 2023 | Amount | Seed - EMN | Valuation | The Kale Fund , dsm firmenich |
|
| Feb, 2019 | Amount | Seed - EMN | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EMN
EMN has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Ajinomoto, dsm-firmenich and PeakBridge VC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PeakBridge VC is focused on investing in FoodTech innovations.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Private equity investments are provided to support business growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EMN
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EMN
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emn Comparisons
Competitors of EMN
EMN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MEND, Lanhao Biotech, Synofit, Collagen Msm Plus and Interpath Global, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of dietary supplements to manage body immunity power
|
|
| domain | founded_year | HQ Location |
Oral regenerative restoration and medical aesthetics products are developed.
|
|
| domain | founded_year | HQ Location |
Provides natural supplements for joint, heart, and digestive health support.
|
|
| domain | founded_year | HQ Location |
Provides premium supplements for joint health using collagen, MSM, and essential vitamins.
|
|
| domain | founded_year | HQ Location |
Researches and develops joint health supplements for humans and animals globally.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Emn
Frequently Asked Questions about EMN
When was EMN founded?
EMN was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is EMN located?
EMN is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Who is the current CEO of EMN?
Eric J Zimmerman is the current CEO of EMN. They have also founded this company.
Is EMN a funded company?
EMN is a funded company, having raised a total of $6.2M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Feb 19, 2019.
What does EMN do?
EMN was founded in 2016 in Toronto, Canada, within the health and nutrition sector. Clinical-grade products are developed to address specific medical requirements, such as reducing postoperative insulin resistance through PREcovery, a complex carbohydrate drink mix, and supporting rehabilitation, wound healing, and protein management for ill or aging individuals via ISOlution, a whey protein isolate powder. Operations focus on product formulation for clinical use.
Who are the top competitors of EMN?
EMN's top competitors include MEND, Lanhao Biotech and Synofit.
What products or services does EMN offer?
EMN offers ENROUTE and ISOLUTION.
Who are EMN's investors?
EMN has 6 investors. Key investors include Ajinomoto, dsm-firmenich, PeakBridge VC, Elder Ventures, and The Kale Fund.